Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera ... version of Lutathera (lutetium Lu 177 dotatate) to the US market.

The Swiss pharma group said it would continue to work with Siemens Healthineers to support and supply its radioligand therapies (RLTs), which include Lutathera (lutetium [Lu177] dotatate ...

A multi-centre, stratified, open, randomized, comparator-controlled, parallel group phase II trial comparing adjuvant treatment with 177Lu-DOTATATE to standard of care in patients after resection of ...

Australasian Gastro-Intestinal Trials Group (AGITG) STOPNET: A randomized study of cessation of somatostatin analogues (SSA) after peptide receptor radionuclide therapy (PRRT) in mid, hind-gut, and ...

A panelist discusses how NCCN guidelines now include cabozantinib as a category 1 recommendation for gastrointestinal (GI) ...

Therapy can be expensive, even with online platforms. Truly free online therapy options are rare, and most free therapy options use trained volunteer listeners over fully qualified therapists.

Infant With Rare, Incurable Disease Is First to Successfully Receive Personalized Gene Therapy Treatment May 15, 2025 — A research team has developed and safely delivered a personalized gene ...